The effects of dutasteride on mood, HPA [hypothalamic-pituitary-adrenal] axis, and serum allopregnanolone levels in women with menstrual-related mood disorders and controls
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Dutasteride (Primary)
- Indications Premenstrual dysphoric disorder
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 12 Mar 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
- 09 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.